Tucson, AZ, United States of America

Michael W Riggs

USPTO Granted Patents = 8 

Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 2000-2014

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Discovering the Innovations of Michael W. Riggs

Introduction

Michael W. Riggs, based in Tucson, AZ, is an accomplished inventor with a remarkable portfolio of eight patents. His inventive work focuses on enhancing therapeutic and prophylactic methods through innovative biotechnological approaches. Riggs has made significant contributions to the field, showcasing his commitment to advancing science and technology.

Latest Patents

Among his latest patents, Riggs has developed innovative fusion proteins that serve as targeted cryptosporidium biocides. These inventions comprise a microorganism targeting molecule, such as an immunoglobulin, fused with a biocide. Riggs' work emphasizes the therapeutic and prophylactic applications of these fusion proteins across various fields, highlighting their potential to address health challenges posed by microorganisms.

Career Highlights

Throughout his career, Riggs has been associated with Iogenetics, LLC, where he has contributed to groundbreaking research and development in biocides and protein technology. His extensive experience and dedication to innovation have established him as a notable figure in the field of biotechnology.

Collaborations

Michael W. Riggs has collaborated with talented professionals like Lance E. Perryman and Michael Imboden. These partnerships have fostered a creative environment, allowing for the exchange of ideas and enhancing the potential for impactful discoveries.

Conclusion

In conclusion, Michael W. Riggs stands out as an inventive force in the realm of biotechnology. With his eight patents and focused innovations in targeted cryptosporidium biocides, Riggs continues to push the boundaries of science, demonstrating the vital role of inventors in shaping the future of healthcare and biotechnological advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…